Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

9473	Companies
185416	Keywords
117771	Articles
99291	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 10/13/2025 at 00:10, 1 month 23 days ago

Moderna Reports Encouraging Early Results for Cancer Therapy

Cancer Therapy Moderna ESMO Congress MRNA-4359 Immune Evasion
PRESS RELEASE

published on 10/13/2025 at 00:05, 1 month 23 days ago

Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
Moderna's mRNA-4359 advances to Phase 2 in CPI-R/R melanoma patients. Promising data on tumor response rates and safety presented at ESMO Congress 2025

Moderna Phase 2 MRNA-4359 CPI-R/R Melanoma Tumor Response
BRIEF

published on 09/25/2025 at 01:06, 2 months 10 days ago

Moderna Launches New Manufacturing and R&D Facility in the UK

MRNA Vaccines NHS Moderna UK Facility Health Resilience Pandemic Readiness
PRESS RELEASE

published on 09/25/2025 at 01:01, 2 months 10 days ago

Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
Moderna's Innovation and Technology Centre in Oxfordshire is now operational, producing British-made mRNA vaccines for the UK population and advancing mRNA science in various areas

Innovation UK Moderna MRNA Vaccines Technology Centre
BRIEF

published on 09/23/2025 at 13:05, 2 months 11 days ago

Moderna's mNEXSPIKE Shows Strong Immune Response Against COVID-19 LP.8.1 Variant

COVID-19 Vaccine Moderna Immune Response LP.8.1 Variant MNEXSPIKE
PRESS RELEASE

published on 09/23/2025 at 13:00, 2 months 11 days ago

Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
Moderna's 2025-2026 mNEXSPIKE formula shows significant increase in LP.8.1-neutralizing antibodies, demonstrating strong immune responses against COVID-19 strains. Preliminary immunogenicity data supports the efficacy and safety of the vaccine

COVID-19 Vaccine Moderna MNEXSPIKE Immunogenicity Data LP.8.1-neutralizing Antibodies
BRIEF

published on 09/19/2025 at 21:40, 2 months 15 days ago

Moderna delivers first Canadian-made mRNA vaccines

COVID-19 Canada Moderna MRNA Vaccines Local Production
BRIEF

published on 09/19/2025 at 21:15, 2 months 15 days ago

Moderna Delivers First Canadian-Made mRNA Vaccines

Health Canada Moderna MRNA Vaccines Canadian Vaccine Production Spikevax Approval National Health Security
PRESS RELEASE

published on 09/19/2025 at 21:10, 2 months 15 days ago

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories
Moderna ships first made-in-Canada mRNA vaccines, advancing domestic production capacity and national health security. Updates on Canada's COVID-19 public vaccination program and regulatory approvals

COVID-19 Canada Moderna MRNA Vaccines Vaccination Program
BRIEF

published on 09/16/2025 at 12:05, 2 months 18 days ago

Moderna's New COVID-19 Vaccine Formula Shows Promising Results

FDA Approval COVID-19 Vaccine Moderna Spikevax LP.8.1 Variant

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 14 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 19 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 49 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 44 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 49 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:30, 19 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 44 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 49 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 49 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 49 minutes ago

Official List Notice

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 4 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 49 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 4 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 5 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE